Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes Academic Article uri icon

Overview

MeSH Major

  • Amlodipine
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Benzazepines
  • Coronary Disease
  • Diabetes Complications
  • Hydrochlorothiazide
  • Hypertension

abstract

  • In patients with diabetes and hypertension, combining a renin-angiotensin system blocker with amlodipine, compared with hydrochlorothiazide, was superior in reducing cardiovascular events and could influence future management of hypertension in patients with diabetes. (Avoiding Cardiovascular Events Through COMbination Therapy in Patients Living With Systolic Hypertension [ACCOMPLISH]; NCT00170950).

publication date

  • June 29, 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2010.02.046

PubMed ID

  • 20620720

Additional Document Info

start page

  • 77

end page

  • 85

volume

  • 56

number

  • 1